Arcturus Therapeutics

PriceArcturus Therapeutics

ARCT

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

Historical stock price chart and annual return over the past years

-77%

5 years

% Total

ARCT
-26%

5 years

Annual Return

ARCT